The Cleveland Guardians are facing a critical juncture that could define their future—their middle infield is in desperate need of a turnaround. With a quiet offseason marked only by re-signing backup catcher Austin Hedges and adding a few relievers, the team’s lineup remains largely unchanged from last season, when they ranked a dismal 28th in scoring. Here’s the kicker: they were the only bottom-10 scoring team to make the postseason, a feat that feels more like luck than sustainability. But here’s where it gets controversial: can they really afford to rely on internal improvements to fix their offensive woes, especially in the middle infield? And this is the part most people miss—their budgetary constraints might force them to bet on unproven prospects rather than making splashy moves. Let’s dive into how this could play out.
Cleveland’s financial limitations mean free agency isn’t a viable path to success, and trading top prospects for established stars is unlikely. Instead, they’ll probably settle for smaller, short-term deals, like adding a right-handed outfield bat to replace Lane Thomas. Paul Hoynes of Cleveland.com suggests this is exactly what’s on the horizon. However, the real challenge lies in the middle infield, where last season’s performance was, frankly, abysmal. Cleveland’s middle infielders combined for a .225/.289/.359 slash line and a 27.6% strikeout rate—second-worst in the MLB. With the 2024 first overall pick, Travis Bazzana, looming on the horizon, this is an area that demands immediate attention.
The Incumbents: A Tale of Unfulfilled Potential
Last season’s middle infield was a three-man rotation: Gabriel Arias at shortstop, Daniel Schneemann in a utility role (primarily second base), and Brayan Rocchio bouncing between positions. Angel Martínez also saw time at second base but was more of a center field option. None of these players impressed offensively, with wRC+ scores 21 to 26 points below league average. Rocchio led the group with a modest .233 batting average and five home runs in 115 games, while Arias, Schneemann, and Martínez each hit 11 or 12 homers. Rocchio showed some promise in the second half, batting .257/.313/.376, but the others struggled mightily after the All-Star Break.
The Prospects: Hope on the Horizon?
Travis Bazzana, the top pick in the 2024 draft, is the name on every Guardians fan’s lips. Despite being slowed by oblique injuries, he posted solid numbers in the minors (.245/.389/.424) and could be MLB-ready by Opening Day. But here’s the twist: his patient approach at the plate led to both high walk rates (17.6%) and strikeouts (24.3%), raising questions about his consistency. Is he already a better bet than Arias or Schneemann? It’s a debate worth having.
Then there’s Juan Brito, a 24-year-old second base prospect who’s been on the 40-man roster for three years but has yet to debut due to injuries. Brito isn’t a defensive standout, but his career OPS above .800 at every level—including .255/.366/.442 in Triple-A—makes him an intriguing option for a lineup starved for production. If Bazzana gets the Opening Day nod, Brito might need an injury or a slump to get his shot.
The Wild Card: Angel Genao
At just 21, shortstop prospect Angel Genao is a long shot for the Opening Day roster, but his solid Double-A performance (.259/.323/.359) suggests he could be a factor by midseason. Scouts see him as a potential everyday player, but he’s still raw on both offense and defense. Could he be the late-season spark the Guardians need?
The Bigger Question: Can Internal Growth Save the Season?
Here’s the bold truth: Cleveland’s middle infield is a gamble. Rocchio, Arias, and Schneemann haven’t proven they can carry the load, and prospects like Bazzana and Brito are unproven at the MLB level. If the Guardians don’t make a significant external move, they’re betting their season on players who, so far, haven’t shown they can deliver. But is that a risk worth taking, or should they rethink their strategy entirely?
What do you think? Are the Guardians setting themselves up for success, or are they overlooking a critical weakness? Let’s hear your take in the comments—this is one debate that’s far from settled.